Response to: Correspondence on "Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure" by Yalta et al

Heart. 2021 Dec;107(23):1922-1923. doi: 10.1136/heartjnl-2021-320174. Epub 2021 Oct 16.
No abstract available

Keywords: diabetes mellitus; heart failure.

Publication types

  • Letter
  • Comment

MeSH terms

  • Glucose
  • Heart Failure* / drug therapy
  • Humans
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
  • Symporters*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Sodium
  • Glucose